Disc Medicine Inc. (IRON): H.C. Wainwright Sees 116% Price Potential - Bitopertin Could Prevent Liver Damage in [EPP Patients]

Disc Medicine Inc. (IRON) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel treatments for patients with severe hematological diseases. The company focuses on the targeted modulation of fundamental biological pathways related to red blood cells, particularly heme biosynthesis and iron metabolism. Broad Pipeline Disc Medicine has made significant progress in recent months in developing its pipeline. The company takes an innovative approach to modulate the formation and function...